Please login to the form below

Not currently logged in
Email:
Password:

GE’s Fraser Black joins BioCity Scotland as MD

Replaces Ian Webster at Scottish life sciences hub

Fraser Black has been appointed as managing director at BioCity Scotland – a life sciences hub based at an old MSD facility in central Scotland.

He joins from GE Life Sciences where he was global services solutions director, and takes over from Ian Webster who had been managing director at BioCity Scotland since its launch in January, 2012.

In his new role, Black will oversee the collection of new bioscience and life sciences companies, including relationship-building with both corporate partners and the local community.

“In Newhouse, we have the resources and exceptional facilities to build a world class hub of successful life science businesses in the central belt of Scotland, and I believe the potential to add real value to the economy is enormous,” said Black. “This is the goal I will work towards as we collectively build the BioCity community here.”

Black had been at GE Life Sciences 2005 having previously held VP positions with Amersham Bioscience in both bioscience services and sales and marketing. He was also president of Hoefer Pharmacia Biotech.

“He brings business development experience honed in the international life sciences arena, as well as world-class team-building skills so we are in very good hands,” said Dr Louis Nisbet, BioCity Scotland chair.

9th July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

Genetic Digital provides strategically driven digital solutions for healthcare, pharma & life sciences brands so they can optimise their web...

Latest intelligence

MORE MONEY FOR THE NHS – BUT IS THIS THE ANSWER?
Paul Mannu of Cello Health Insight says that politicians opening their pre-election cheque books can’t put the NHS where it needs to be – but pharma can play a major...
Medius Deal Watch
Pharma deals in February 2015
Pfizer and Valeant led the way during a respectable, if not record-breaking, month for mergers, acquisitions and collaborations...
Medius Deal Watch
Medius Deal Watch table for February 2015
The top major pharma mergers, acquisitions and collaborations during the month were led by the Pfizer/Hospira and Salix/Valeant deals...

Infographics